Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability

Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability

US Patent 11382877 · Granted Jul 12, 2022

Estimated economic value: $476,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenz2024
Pharmaceutical formulation of arsenic trioxide2023
Formulations for the treatment of pain2020
Methods and compositions for treatment of cancer2020
Formulations with enhanced stability and bioavailability for administration of (2018
Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone2017
Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone2015
Compositions and methods for prevention and treatment of wounds2015
Formulations for the treatment of pain2014
Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkox2013
Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substitu2011
Biodegradable polymer blends for drug delivery1999